» Articles » PMID: 28353409

What Do We Know About the Role of Regulatory B Cells (Breg) During the Course of Infection of Two Major Parasitic Diseases, Malaria and Leishmaniasis?

Overview
Date 2017 Mar 30
PMID 28353409
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Parasitic diseases, such as malaria and leishmaniasis, are relevant public health problems worldwide. For both diseases, the alarming number of clinical cases and deaths reported annually has justified the incentives directed to better understanding of host's factors associated with susceptibility to infection or protection. In this context, over recent years, some studies have given special attention to B lymphocytes with a regulator phenotype, known as Breg cells. Essentially important in the maintenance of immunological tolerance, especially in autoimmune disease models such as rheumatoid arthritis and experimentally induced autoimmune encephalomyelitis, the function of these lymphocytes has so far been poorly explored during the course of diseases caused by parasites. As the activation of Breg cells has been proposed as a possible therapeutic or vaccine strategy against several diseases, here we reviewed studies focused on understanding the relation of parasite and Breg cells in malaria and leishmaniasis, and the possible implications of these strategies in the course of both infections.

Citing Articles

The current understanding of the phenotypic and functional properties of human regulatory B cells (Bregs).

Ahsan N, Lourenco S, Psyllou D, Long A, Shankar S, Bashford-Rogers R Oxf Open Immunol. 2024; 5(1):iqae012.

PMID: 39346706 PMC: 11427547. DOI: 10.1093/oxfimm/iqae012.


Current understanding of the immune potential of B-cell subsets in malarial pathogenesis.

Kalkal M, Das J Front Microbiol. 2023; 14:1046002.

PMID: 36778886 PMC: 9909418. DOI: 10.3389/fmicb.2023.1046002.


Unraveling the role of Breg cells in digestive tract cancer and infectious immunity.

Moreira H, Dobosz A, Cwynar-Zajac L, Nowak P, Czyzewski M, Barg M Front Immunol. 2023; 13:981847.

PMID: 36618354 PMC: 9816437. DOI: 10.3389/fimmu.2022.981847.


Humoral response in Leishmaniasis.

Conde L, Maciel G, de Assis G, Freire-de-Lima L, Nico D, Vale A Front Cell Infect Microbiol. 2022; 12:1063291.

PMID: 36579347 PMC: 9791258. DOI: 10.3389/fcimb.2022.1063291.


Immunosuppression in Malaria: Do Parasites Hijack the Host?.

Lamsfus Calle C, Mordmuller B, Singh A Pathogens. 2021; 10(10).

PMID: 34684226 PMC: 8536967. DOI: 10.3390/pathogens10101277.


References
1.
Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg R, Bhan A . Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity. 2002; 16(2):219-30. DOI: 10.1016/s1074-7613(02)00274-1. View

2.
Schofield L, Grau G . Immunological processes in malaria pathogenesis. Nat Rev Immunol. 2005; 5(9):722-35. DOI: 10.1038/nri1686. View

3.
Gaubert S, Viana da Costa A, Maurage C, Lima E, Fontaine J, Lafitte S . X-linked immunodeficiency affects the outcome of Schistosoma mansoni infection in the murine model. Parasite Immunol. 1999; 21(2):89-101. DOI: 10.1046/j.1365-3024.1999.00205.x. View

4.
DiLillo D, Weinberg J, Yoshizaki A, Horikawa M, Bryant J, Iwata Y . Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function. Leukemia. 2012; 27(1):170-82. PMC: 3742013. DOI: 10.1038/leu.2012.165. View

5.
Wei F, Chang Y, Wei W . The role of BAFF in the progression of rheumatoid arthritis. Cytokine. 2015; 76(2):537-544. DOI: 10.1016/j.cyto.2015.07.014. View